Characteriza*on of Soma*c Muta*ons in Cancer Genomes
|
|
- John Quinn
- 5 years ago
- Views:
Transcription
1 Characteriza*on of Soma*c Muta*ons in Cancer Genomes Ben Raphael Department of Computer Science Center for Computa*onal Molecular Biology
2 Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger muta*ons Founder cell typical tumor : Driver muta*on Time (cell divisions) ~10 driver muta*ons 100 s 1000 s of passenger muta*ons Cell popula*on CGTAATTAG CGTCATTAG Single nucleo*de variant Copy number variants Structural variants
3 Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger muta*ons Founder cell typical tumor : Driver muta*on Time (cell divisions) ~10 driver muta*ons 100 s 1000 s of passenger muta*ons Cell popula*on Sequence genome
4 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. Algorithms Human genome: ~3 billion bp Next- genera6on DNA sequencing CATTCAGTAG GGTAGTTAG TATAATTAG AGCCATTAG GGTAAACTAG CGTACCTAG s million reads Read: bp Genome and Muta6ons
5 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. 1. De novo assembly Algorithms Human genome: ~3 billion bp Next- genera6on DNA sequencing 2. Resequencing CATTCAGTAG GGTAGTTAG TATAATTAG AGCCATTAG GGTAAACTAG CGTACCTAG s million reads Read: bp
6 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. 1. De novo assembly Algorithms Human genome: ~3 billion bp Next- genera6on DNA sequencing 2. Resequencing Right breakpoint (a,b) Geometric Analysis of Structural Varia*on (GASV) Lea breakpoint Bashir, et al. PLOS Comp. Biol. (2008) Sindi et al. Bioinforma3cs/ISMB (2009), Sindi et al. (2011) [In revision] GASVPro
7 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. Algorithms gene Human genome: ~3 billion bp Next- genera6on DNA sequencing Reads of bp Genome and Muta6ons 2. Dis6nguish func*onal (driver) muta*ons from background (passenger) muta*ons.
8 Driver Muta*ons Next- genera*on DNA sequencing gene : soma*c muta*on Recurrent muta*ons/mutated genes à driver muta*ons Dis6nguish func*onal (driver) muta*ons from background (passenger) muta*ons.
9 Recurrent Muta*ons genes pa6ents f Muta6on matrix = mutated = 1 = not mutated = 0 gene : soma*c muta*on Mutated more that expected by chance? Single- gene test à Mul*ple hypotheses correc*on 91 GBM samples. TCGA, Nature (2008) 316 OV samples. TCGA, Nature (2011) Table 2 Significantly mutated genes in HGS-OvCa Gene No. of mutations No. validated No. unvalidated TP BRCA CSMD NF CDK FAT GABRA BRCA RB Validated mutations are those that have been confirmed with an independent assay. Most of them are
10 Mutated Pathways Standard approach: enrichment of muta*ons on known pathways. genes pa6ents p53 pathway: 87% of pa*ents Limita6ons Only exis*ng pathways are tested. Topology of pathways ignored. Pathways are interconnected (crosstalk). TCGA GBM. Nature, 2008.
11 Pathways à Groups " The view that muta*ons affect discrete signaling pathways...has proved to be too simplis*c. [Cancer genes] depend on one another for their selec*ve advantage, and they affect mul1ple pathways that intersect and overlap. Frank McCormick, Signalling networks that cause cancer, Trends in Gene3cs (1999).
12 Advantage of Large Datasets? Prior knowledge of groups of genes Known pathways Interac*on Network None Prior knowledge Number of Hypotheses (< 6 genes) (< 6 genes)
13 Two Algorithms Prior knowledge of groups of genes Known pathways Interac*on Network None Prior knowledge HotNet subnetworks of interac*on network Number of Hypotheses Dendrix Exclusive gene sets
14 HotNet: Problem Defini*on Given: 1. Network G = (V, E) V = genes. E = interac*ons b/w genes 2. Binary muta*on matrix Genes = mutated = not mutated Pa6ents Find: Connected subnetworks mutated in a significant number of pa*ents mutated in pa*ent if 1 gene mutated in pa*ent
15 (Local) Topology Maoers Single path between mutated genes Path between mutated genes is one of many through node. Example: TP53 has 238 neighbors in HPRD network
16 Heat Diffusion on Graph
17 Mutated subnetworks: HotNet* Muta6on Matrix Genes Human Interac6on Network = mutated genes Pa*ents (1) Muta6on heat diffusion Extract significantly hot subnetworks Hot (2) Cold *F. Vandin, E. Upfal, and B. J. Raphael. J. Comp.Biol. (2011). Also RECOMB (2010).
18 Sta*s*cal Test Muta6on Matrix Genes Random Binary Matrix Genes Pa*ents Pa*ents X s = number of subnetworks s genes Two- stage mul6- hypothesis test: Rigorously bound FDR.
19 HPRD network nodes edges Results: TCGA Ovarian ~20000 Genes 316 Pa*ents Muta*on & copy number HotNet 27 subnetworks with 7 genes (P < 0.03) TCGA. Nature (2011)
20 Ovarian Subnetworks TCGA. Nature (2011)
21 Ovarian Subnetworks Kegg Pathway Notch signaling (p < 6x10-7 ) 12/27 subnetworks significantly overlap known pathways (KEGG) or protein complexes (PINdb) TCGA. Nature (2011)
22 Ovarian Subnetworks Known Protein Complexes Cohesin (P < 5x10-8 ) Kegg Pathway Cell cycle (P < 2x10-5 ) TCGA. Nature (2011)
23 Results: Brain Cancer 91 Samples HPRD network nodes edges 601 Genes Muta*on & copy number HotNet 2 subnetworks with 20 genes (P < 0.01)
24 Brain: Muta*ons + Copy number RTK/RAS/PI(3)K RB1 p53 Subnetwork Enrichment p- val s RTK/RAS/PI(3)K P53 RB x10-6 4x
25 Two Algorithms Prior knowledge of groups of genes Known pathways Interac*on Network None Prior knowledge HotNet subnetworks of interac*on network Number of Hypotheses Dendrix Exclusive gene sets
26 Pathways and Muta*ons Driver muta3ons are rare. Cancer pathway has one driver muta*on (gene) per pa*ent [Vogelstein and K. W. Kinzler (2004), Yeang, McCormick, and Levine (2008)] 1. Exclusivity Genes EGFR RAF cell membrane RAS MEK Pa6ents MAPK Transcrip*on factors [Thomas, et al. (2007)]
27 Pathways and Muta*ons Driver muta3ons are rare. Cancer pathway has one driver muta*on (gene) per pa*ent [Vogelstein and K. W. Kinzler (2004), Yeang, McCormick, and Levine (2008)] 1. Exclusivity EGFR RAF cell membrane RAS Many pa*ents have muta*on in important cancer pathway. 2. Coverage MAPK MEK Transcrip*on factors
28 De novo driver exclusivity (Dendrix*) Given: Binary muta*on matrix A Find: Set M of genes with: Maximum Coverage: maximum number of pa*ents have 1 muta*on in M Mutual Exclusivity: all pa*ents have 1 muta*on in M pa6ents ; genes Difficult computa*onal problem (NP- hard) *Vandin, Upfal, & Raphael. Genome Res. (Advance online) Also RECOMB 2011.
29 De novo driver exclusivity (Dendrix*) Given: Binary muta*on matrix A Find: Set M of genes with: High Coverage: many pa*ents have a 1 muta*on in M Approximate Exclusivity: most pa*ents have 1 muta*on in M Finding largest M is difficult! Greedy algorithm and MCMC algorithm Theore*cal results on convergence and op*mality. pa6ents ; genes Dendrix++: extension with scoring based on probabilis*c model *Vandin, Upfal, & Raphael. Genome Res. (Advance online) Also RECOMB 2011.
30 Experimental Results Cancer data 1. Known muta6ons in mul6ple cancer types [Thomas et al. (2007)] 238 known muta*ons in 1000 pa*ents of 17 different cancer types 2. Lung Adenocarcinoma [Ding et al. (2008)] 623 sequenced genes in 188 pa*ents 3. Brain cancer (GBM) [TCGA (2008)] 601 sequenced genes in 84 pa*ents Array copy number data on all genes 4. Acute Myleloid Leukemia (AML) [TCGA] Whole exome sequencing on ~200 pa*ents 5. Breast Cancer (BRCA) [TCGA] Whole exome sequencing Array copy number on ~400 pa*ents
31 Known muta*ons in mul*ple cancer types 238 known muta*ons tumors from 17 cancer types [Thomas, et al. (2007)] Muta*on: Exclusive Co- occurring None 8 muta*ons cover 94% of mutated tumors Only 15 tumors with >1 muta*on (p < 0.01)
32 Lung Adenocarcinoma 623 sequenced genes in 188 pa*ents [Ding et al. (2008)] (p < 0.01) (p < 0.01)
33 Brain Cancer (GBM) Muta*ons (single- nucleo*de and copy number) for 601 genes in 84 samples [TCGA (2008)] (p < 0.01) (p < 0.01) (p < 0.01)
34 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. Algorithms gene Human genome: ~3 billion bp Next- genera6on DNA sequencing Reads of bp Genome and Muta6ons 2. Dis6nguish func*onal (driver) muta*ons from background (passenger) muta*ons.
35 Summary Prior knowledge of groups of genes Known pathways Prior knowledge Interac*on Network None HotNet subnetworks of interac*on network Number of Hypotheses Dendrix Exclusive gene sets Future: Incorporate more data types (methyla*on, gene expression). Perform pre/post filtering of predic*ons.
36 Acknowledgements Fabio Vandin Eli Upfal Hsin- Ta Wu Edward Rice Tim Ley Li Ding Elaine Mardis Rick Wilson and others Funding
37 Shameless Adver*sing 1) Soaware available. 2) Student* and postdoc posi6ons available. * Ph.D. programs in Computer Science, Computa*onal Biology, and Molecular Biology. Web: hop://cs.brown.edu/people/braphael
Simultaneous Identification of Multiple Driver Pathways in Cancer
Simultaneous Identification of Multiple Driver Pathways in Cancer Mark D. M. Leiserson 1, Dima Blokh 2, Roded Sharan 2., Benjamin J. Raphael 1. * 1 Department of Computer Science and Center for Computational
More informationA Robust Method for Identifying Mutated Driver Pathways in Cancer
, pp.392-397 http://dx.doi.org/10.14257/astl.2016. A Robust Method for Identifying Mutated Driver Pathways in Cancer Can-jun Hu and Shu-Lin Wang * College of computer science and electronic engineering,
More informationAML Genomics 11/27/17. Normal neutrophil maturation. Acute Myeloid Leukemia (AML) = block in differentiation. Myelomonocy9c FAB M5
AML Genomics 1 Normal neutrophil maturation Acute Myeloid Leukemia (AML) = block in differentiation AML with minimal differen9a9on FAB M1 Promyelocy9c leukemia FAB M3 Myelomonocy9c FAB M5 2 1 Principle
More informationInference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 C.J.Vaske et al. May 22, 2013 Presented by: Rami Eitan Complex Genomic
More informationUnderstanding Genotype- Phenotype relations in Cancer via Network Approaches
AlgoCSB Algorithmic Methods in Computational and Systems Biology Understanding Genotype- Phenotype relations in Cancer via Network Approaches Teresa Przytycka NIH / NLM / NCBI Phenotypes Journal Wisla
More informationIdentifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine
Raphael et al. Genome Medicine 2014, 6:5 REVIEW Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine Benjamin J Raphael 1,2*, Jason R Dobson 1,2,3,
More informationClassifica4on. CSCI1950 Z Computa4onal Methods for Biology Lecture 18. Ben Raphael April 8, hip://cs.brown.edu/courses/csci1950 z/
CSCI1950 Z Computa4onal Methods for Biology Lecture 18 Ben Raphael April 8, 2009 hip://cs.brown.edu/courses/csci1950 z/ Binary classifica,on Given a set of examples (x i, y i ), where y i = + 1, from unknown
More informationNetwork-based interpreta1on of perturba1ons to living systems
Network-based interpreta1on of perturba1ons to living systems Sushmita Roy sroy@biostat.wisc.edu Computa1onal Network Biology Biosta2s2cs & Medical Informa2cs 826 Computer Sciences 838 hbps://compnetbiocourse.discovery.wisc.edu
More informationMissing Heritablility How to Analyze Your Own Genome Fall 2013
Missing Heritablility 02-223 How to Analyze Your Own Genome Fall 2013 Heritability Heritability: the propor>on of observed varia>on in a par>cular trait (as height) that can be agributed to inherited gene>c
More informationIntegrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers
Integrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers Songjian Lu, PhD, Xinghua Lu, MD. PhD Dept. Biomedical Informatics, Univ. Pittsburgh, PA 15232
More informationCancer gene discovery via network analysis of somatic mutation data. Insuk Lee
Cancer gene discovery via network analysis of somatic mutation data Insuk Lee Cancer is a progressive genetic disorder. Accumulation of somatic mutations cause cancer. For example, in colorectal cancer,
More informationIntroduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015
Introduction to Cancer Bioinformatics and cancer biology Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015 Why cancer bioinformatics? Devastating disease, no cure on the horizon Major
More informationCopy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015
Copy Number Varia/on Detec/on Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015 Today s Goals Understand the applica5on and capabili5es of using targe5ng sequencing and CNV calling
More informationIdentifying Mutated Core Modules in Glioblastoma by Integrative Network Analysis
Identifying Mutated Core Modules in Glioblastoma by Integrative Network Analysis Junhua Zhang, Shihua Zhang, Yong Wang, Junfei Zhao and Xiang-Sun Zhang National Center for Mathematics and Interdisciplinary
More informationPan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes Nature Genetics 47, 106-114 (2015) doi:101038/ng3168 Max Leiserson RECOMB 2015 April
More informationLong non coding RNA in the pea aphid; iden3fica3on and compara3ve expression in sexual and asexual embryos
Long non coding RNA in the pea aphid; iden3fica3on and compara3ve expression in sexual and asexual embryos Fabrice Legeai, Thomas Derrien, Valen3n Wucher, Audrey David, Gael Le Trionnaire and Denis Tagu
More informationCharacterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser
Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why
More informationDecades of cancer research have demonstrated that. Computational approaches for the identification of cancer genes and pathways
Computational approaches for the identification of cancer genes and pathways Christos M. Dimitrakopoulos 1,2 and Niko Beerenwinkel 1,2 * High-throughput DNA sequencing techniques enable large-scale measurement
More informationGenetic Tests and Genetic Counseling How to Analyze Your Own Genome
Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and
More informationStructured Association Advanced Topics in Computa8onal Genomics
Structured Association 02-715 Advanced Topics in Computa8onal Genomics Structured Association Lasso ACGTTTTACTGTACAATT Gflasso (Kim & Xing, 2009) ACGTTTTACTGTACAATT Greater power Fewer false posi2ves Phenome
More informationExploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser
Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Melissa S. Cline 1*, Brian Craft 1, Teresa Swatloski 1, Mary Goldman 1, Singer Ma 1, David Haussler 1, Jingchun Zhu 1 1 Center for Biomolecular
More informationEvolu&on of Disease genes
Evolu&on of Disease genes Many human diseases are caused by muta1ons in single genes A synthe&c pathway and associated diseases Autosomal dominant condi&ons Dominant Disorders A single mutant gene is sufficient
More informationEvolu+on of Disease genes
Evolu+on of Disease genes Many human diseases are caused by muta1ons in single genes 1 A synthe+c pathway and associated diseases Autosomal dominant condi+ons 2 Dominant Disorders A single mutant gene
More informationExpanded View Figures
Solip Park & Ben Lehner Epistasis is cancer type specific Molecular Systems Biology Expanded View Figures A B G C D E F H Figure EV1. Epistatic interactions detected in a pan-cancer analysis and saturation
More informationIntegrative Omics for The Systems Biology of Complex Phenotypes
Integrative Omics for The Systems Biology of Complex Phenotypes Mehmet Koyutürk Case Western Reserve University (1) Electrical Engineering and Computer Science (2) Center for Proteomics and Bioinformatics
More informationCopy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics
Copy Number Variations and Association Mapping 02-715 Advanced Topics in Computa8onal Genomics SNP and CNV Genotyping SNP genotyping assumes two copy numbers at each locus (i.e., no CNVs) CNV genotyping
More informationNicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY
A Somewhat Different View of the Gene3c Portrait of Chronic Lymphocy3c Leukemia Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY Acknowledgments Davide Bagnara
More informationReconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer
Reconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer Darryl Shibata Professor of Pathology University of Southern California Keck School of Medicine dshibata@usc.edu
More informationEpigene.cs: What is it and how it effects our health? Overview. Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa
Epigene.cs: What is it and how it effects our health? Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa Overview Basic Background Epigene.cs in general Epigene.cs in cancer Epigene.cs
More informationConsidera*ons when undergoing personal genotyping
Considera*ons when undergoing personal genotyping Kelly Ormond, MS, CGC Louanne Hudgins, MD, FACMG January 19, 2011 GENE 210 Disclosures and introduc*ons Professor Ormond provided paid consulta*on for
More informationDawnRank: discovering personalized driver genes in cancer
Hou and Ma Genome Medicine 2014, 6:56 METHOD Open Access DawnRank: discovering personalized driver genes in cancer Jack P Hou 1,2 and Jian Ma 1,3* Abstract Large-scale cancer genomic studies have revealed
More informationClasificación Molecular del Cáncer de Próstata. JM Piulats
Clasificación Molecular del Cáncer de Próstata JM Piulats Introduction The Gleason score is the major method for prostate cancer tissue grading and the most important prognostic factor in this disease.
More informationNovel treatments for SCC Andrés Felipe Cardona, MD MS PhD.
Novel treatments for SCC Andrés Felipe Cardona, MD MS PhD. Clinical and Transla,onal Oncology Group Ins,tute of Oncology, Fundación Santa fe de Bogotá Clinical Epidemiology Cochrane Colombian Branch /
More informationCancer Genomics and Personalized Oncology. Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group
Cancer Genomics and Personalized Oncology Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group Cancer in Brazil 600,000 new cases/year Popula0on: 210,867,959 Number of new cases:
More informationResults and Discussion of Receptor Tyrosine Kinase. Activation
Results and Discussion of Receptor Tyrosine Kinase Activation To demonstrate the contribution which RCytoscape s molecular maps can make to biological understanding via exploratory data analysis, we here
More informationVoting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties
by Combining Topological and Data-Driven Properties A. K. M. Azad, Hyunju Lee* School of Information and Communications, Gwangju Institute of Science and Technology, Gwangju, South Korea Abstract Recently,
More informationAnalysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers
Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies
More informationTranscriptome and isoform reconstruc1on with short reads. Tangled up in reads
Transcriptome and isoform reconstruc1on with short reads Tangled up in reads Topics of this lecture Mapping- based reconstruc1on methods Case study: The domes1c dog De- novo reconstruc1on method Trinity
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationCauses of variability in developmental disorders
Causes of variability in developmental disorders Is the medical risk model appropriate for understanding behavioural deficits? Michael Thomas Birkbeck College Workshop: Developmental disorders: co- morbidity,
More informationIdentification of Tissue Independent Cancer Driver Genes
Identification of Tissue Independent Cancer Driver Genes Alexandros Manolakos, Idoia Ochoa, Kartik Venkat Supervisor: Olivier Gevaert Abstract Identification of genomic patterns in tumors is an important
More informationCase Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD
Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Department of Biomedical Informatics Department of Computer Science and Engineering The Ohio State University Review
More informationWhy Pathway/Network Analysis?
6/8/16 More Depth on Pathway and Network Analysis Lincoln Stein Why Pathway/Network Analysis? Drama@c data size reduc@on: 1000 s of genes => dozens of pathways. Increase sta@s@cal power by reducing mul@ple
More informationThe Cancer Genome Atlas & International Cancer Genome Consortium
The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1
More informationOncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies
OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies 2017 Contents Datasets... 2 Protein-protein interaction dataset... 2 Set of known PPIs... 3 Domain-domain interactions...
More informationNGS in tissue and liquid biopsy
NGS in tissue and liquid biopsy Ana Vivancos, PhD Referencias So, why NGS in the clinics? 2000 Sanger Sequencing (1977-) 2016 NGS (2006-) ABIPrism (Applied Biosystems) Up to 2304 per day (96 sequences
More informationInterpreting Diverse Genomic Data Using Gene Sets
Interpreting Diverse Genomic Data Using Gene Sets giovanni parmigiani@dfci.harvard.edu FHCRC February 2012 Gene Sets Leary 2008 PNAS Alterations in the combined FGF, EGFR, ERBB2 and PIK3 pathways. Red:
More informationNetwork-assisted data analysis
Network-assisted data analysis Bing Zhang Department of Biomedical Informatics Vanderbilt University bing.zhang@vanderbilt.edu Protein identification in shotgun proteomics Protein digestion LC-MS/MS Protein
More informationarxiv: v1 [cs.lg] 25 Jan 2016
A new correlation clustering method for cancer mutation analysis Jack P. Hou 1,2,, Amin Emad 3,, Gregory J. Puleo 3, Jian Ma 1,4,*, and Olgica Milenkovic 3,* arxiv:1601.06476v1 [cs.lg] 25 Jan 2016 1 Department
More informationJ. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam, the Netherlands
Inherited arrhythmia syndromes I: What you always wanted to know, but were afraid to ask: The basics of inherited arrhythmia syndromes and gene:cs J. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam,
More informationSCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab
SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA Giuseppe Narzisi, PhD Schatz Lab November 14, 2013 Micro-Assembly Approach to detect INDELs 2 Outline Scalpel micro-assembly pipeline
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20
More informationEXTRACTING SIGNIFICANT SAMPLE-SPECIFIC CANCER MUTATIONS USING THEIR PROTEIN INTERACTIONS
EXTRACTING SIGNIFICANT SAMPLE-SPECIFIC CANCER MUTATIONS USING THEIR PROTEIN INTERACTIONS LIVIU BADEA University Politehnica Bucharest and Bioinformatics Group, ICI 8-10 Averescu Blvd, Bucharest, Romania
More informationGene+c fate mapping. x loxp. Foxp3 3 UTR ROSA26 RFP IRES GFP CRE. STOP loxp. Stable Foxp3 expression. Foxp3 expression in new Treg.
1 Introduc+on (CD4 + CD25 + Foxp3 + )are indispensable for immune homeostasis. Muta+ons in Foxp3 gene leads to fatal autoimmune disorder. Condi+onal dele+on of Foxp3 reprograms cells into pathogenic Th
More informationThe Hierarchical Organization of Normal and Malignant Hematopoiesis
The Hierarchical Organization of Normal and Malignant Hematopoiesis NORMAL Hematopoie2c Stem Cell (HSC) Leukemia Stem Cells (LSC) MPP MLP CMP Leukemic Progenitors MEP GMP B/NK ETP Leukemic Blasts Erythrocytes
More informationThe 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics
More informationThe Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley
The Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley Department of Genetics Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill What is TCGA? The Cancer Genome
More informationInherited breast and ovarian cancer
Inherited breast and ovarian cancer Pr François Duhoux Medical Oncology and Center for Human Genetics Breast Incidence - Mortality.be: 147.5 29.5 Life9me risk : 12% IARC EUCAN Fact Sheets 2 1 Breast cancer
More informationEmerging gene)cs in schizophrenia: Real challenges for crea)ng animal models
Emerging gene)cs in schizophrenia: Real challenges for crea)ng animal models Steven A McCarroll, PhD Stanley Center for Psychiatric Research, Broad Ins7tute Department of Gene7cs, Harvard Medical School
More informationMolEcular Taxonomy of BReast cancer International Consortium (METABRIC)
PERSPECTIVE 1 LARGE SCALE DATASET EXAMPLES MolEcular Taxonomy of BReast cancer International Consortium (METABRIC) BC Cancer Agency, Vancouver Samuel Aparicio, PhD FRCPath Nan and Lorraine Robertson Chair
More informationCancer troublemakers: a tale of usual suspects and novel villains
Cancer troublemakers: a tale of usual suspects and novel villains Abel González-Pérez and Núria López-Bigas Biomedical Genomics Group Lab web: http://bg.upf.edu Driver genes/mutations: the troublemakers
More informationInsights from Sequencing the Melanoma Exome
Insights from Sequencing the Melanoma Exome Michael Krauthammer, MD PhD, December 2 2015 Yale University School Yof Medicine 1 2012 Exome Screens and Results Exome Sequencing of 108 sun-exposed melanomas
More informationCarcinoma mammario triple nega0ve Nuove acquisizioni biologiche. Giuseppe Curigliano MD PhD UNIMI & IEO
Carcinoma mammario triple nega0ve Nuove acquisizioni biologiche Giuseppe Curigliano MD PhD UNIMI & IEO Outline San Antonio Breast Cancer Symposium, December 5-9, 2017 The year of DNA Repair targe?ng Olaparib
More informationIDENTIFYING MASTER REGULATORS OF CANCER AND THEIR DOWNSTREAM TARGETS BY INTEGRATING GENOMIC AND EPIGENOMIC FEATURES
IDENTIFYING MASTER REGULATORS OF CANCER AND THEIR DOWNSTREAM TARGETS BY INTEGRATING GENOMIC AND EPIGENOMIC FEATURES OLIVIER GEVAERT Radiology, Stanford, 1201 Welch Road Stanford, CA 94305 Email: olivier.gevaert@stanford.edu
More informationValida5on of a Microsatellite Instability Assay by NGS
Valida5on of a Microsatellite Instability Assay by NGS Mark R. Miglarese, Ph.D. VP R&D 1 Caris Life Sciences 230,000+ tests performed in 2016 Headquarters: Irving, Texas Laboratory: Phoenix, Arizona 66,000
More informationGenomic tests to personalize therapy of metastatic breast cancers. Fabrice ANDRE Gustave Roussy Villejuif, France
Genomic tests to personalize therapy of metastatic breast cancers Fabrice ANDRE Gustave Roussy Villejuif, France Future application of genomics: Understand the biology at the individual scale Patients
More informationIntegrated genomic analyses of ovarian carcinoma
Integrated genomic analyses of ovarian carcinoma The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published Publisher Bell,
More informationNature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from
Supplementary Figure 1 SEER data for male and female cancer incidence from 1975 2013. (a,b) Incidence rates of oral cavity and pharynx cancer (a) and leukemia (b) are plotted, grouped by males (blue),
More informationPredicting Kidney Cancer Survival from Genomic Data
Predicting Kidney Cancer Survival from Genomic Data Christopher Sauer, Rishi Bedi, Duc Nguyen, Benedikt Bünz Abstract Cancers are on par with heart disease as the leading cause for mortality in the United
More informationTaking a closer look at trio designs and unscreened controls in the GWAS era
Taking a closer look at trio designs and unscreened controls in the GWAS era PGC Sta8s8cal Analysis Call, November 4th 015 Wouter Peyrot, MD, Psychiatrist in training, PhD candidate Professors Brenda Penninx,
More informationExpert-guided Visual Exploration (EVE) for patient stratification. Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland
Expert-guided Visual Exploration (EVE) for patient stratification Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland Oncoscape.sttrcancer.org Paul Lisa Ken Jenny Desert Eric The challenge Given - patient clinical
More informationIdentifying Causal Genes and Dysregulated Pathways in Complex Diseases
Identifying Causal Genes and Dysregulated Pathways in Complex Diseases Yoo-Ah Kim, Stefan Wuchty, Teresa M. Przytycka* National Center for Biotechnology Information, National Library of Medicine, National
More informationGene Ontology and Functional Enrichment. Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein
Gene Ontology and Functional Enrichment Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein The parsimony principle: A quick review Find the tree that requires the fewest
More informationDr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach
Dr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach Department of Health Sciences Section of Biostatistics University of Genoa, Italy Mul%ple
More informationProtein Domain-Centric Approach to Study Cancer Somatic Mutations from High-throughput Sequencing Studies
Protein Domain-Centric Approach to Study Cancer Somatic Mutations from High-throughput Sequencing Studies Dr. Maricel G. Kann Assistant Professor Dept of Biological Sciences UMBC 2 The term protein domain
More informationDGPathinter: a novel model for identifying driver genes via knowledge-driven matrix factorization with prior knowledge from interactome and pathways
DGPathinter: a novel model for identifying driver genes via knowledge-driven matrix factorization with prior knowledge from interactome and pathways Jianing Xi, *, Minghui Wang,2, * and Ao Li,2 School
More informationPa#ern recogni,on and neuroimaging in psychiatry
Pa#ern recogni,on and neuroimaging in psychiatry Janaina Mourao-Miranda Machine Learning and Neuroimaging Lab Max Planck UCL Centre for Computa=onal Psychiatry and Ageing Research Outline Supervised learning
More informationComparing Multifunctionality and Association Information when Classifying Oncogenes and Tumor Suppressor Genes
000 001 002 003 004 005 006 007 008 009 010 011 012 013 014 015 016 017 018 019 020 021 022 023 024 025 026 027 028 029 030 031 032 033 034 035 036 037 038 039 040 041 042 043 044 045 046 047 048 049 050
More informationComputer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015
Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a
More informationGene-microRNA network module analysis for ovarian cancer
Gene-microRNA network module analysis for ovarian cancer Shuqin Zhang School of Mathematical Sciences Fudan University Oct. 4, 2016 Outline Introduction Materials and Methods Results Conclusions Introduction
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28
More informationAdvances in Brain Tumor Research: Leveraging BIG data for BIG discoveries
Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Jill Barnholtz-Sloan, PhD Associate Professor & Associate Director for Bioinformatics and Translational Informatics jsb42@case.edu
More informationSmall RNAs and how to analyze them using sequencing
Small RNAs and how to analyze them using sequencing Jakub Orzechowski Westholm (1) Long- term bioinforma=cs support, Science For Life Laboratory Stockholm (2) Department of Biophysics and Biochemistry,
More informationGlioblastoma pathophysiology: or a
Glioblastoma pathophysiology: A or a? M.J. van den Bent The Brain Tumor Center at Erasmus MC Cancer Center Rotterdam, the Netherlands Pathophysiology: pathophysiology seeks to explain the physiological
More informationS1 Appendix: Figs A G and Table A. b Normal Generalized Fraction 0.075
Aiello & Alter (216) PLoS One vol. 11 no. 1 e164546 S1 Appendix A-1 S1 Appendix: Figs A G and Table A a Tumor Generalized Fraction b Normal Generalized Fraction.25.5.75.25.5.75 1 53 4 59 2 58 8 57 3 48
More informationTranscript reconstruction
Transcript reconstruction Summary I Data types, file formats and utilities Annotation: Genomic regions Genes Peaks bedtools Alignment: Map reads BAM/SAM Samtools Aggregation: Summary files Wig (UCSC) TDF
More informationMultiplexed Cancer Pathway Analysis
NanoString Technologies, Inc. Multiplexed Cancer Pathway Analysis for Gene Expression Lucas Dennis, Patrick Danaher, Rich Boykin, Joseph Beechem NanoString Technologies, Inc., Seattle WA 98109 v1.0 MARCH
More informationNature Biotechnology: doi: /nbt.1904
Supplementary Information Comparison between assembly-based SV calls and array CGH results Genome-wide array assessment of copy number changes, such as array comparative genomic hybridization (acgh), is
More informationHIT ndrive: Multi-driver Gene Prioritization Based on Hitting Time
HIT ndrive: Multi-driver Gene Prioritization Based on Hitting Time Raunak Shrestha 1,2,, Ermin Hodzic 3,, Jake Yeung 2,4,, Kendric Wang 2, Thomas Sauerwald 5, Phuong Dao 6, Shawn Anderson 2, Himisha Beltran
More informationExpanded View Figures
Molecular Systems iology Tumor CNs reflect metabolic selection Nicholas Graham et al Expanded View Figures Human primary tumors CN CN characterization by unsupervised PC Human Signature Human Signature
More informationDe Novo Viral Quasispecies Assembly using Overlap Graphs
De Novo Viral Quasispecies Assembly using Overlap Graphs Alexander Schönhuth joint with Jasmijn Baaijens, Amal Zine El Aabidine, Eric Rivals Milano 18th of November 2016 Viral Quasispecies Assembly: HaploClique
More informationFemale Reproduc.ve System. Kris.ne Kra7s, M.D.
Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Female Reproduc.ve System Outline Cervix Cervical carcinoma Cervical Carcinoma Once the most
More informationClinical Grade Biomarkers in the Genomic Era Observations & Challenges
Clinical Grade Biomarkers in the Genomic Era Observations & Challenges IOM Committee on Policy Issues in the Clinical Development & Use of Biomarkers for Molecularly Targeted Therapies March 31-April 1,
More informationNGS, Cancer and Bioinforma;cs. 20/10/15 Yannick Boursin
NGS, Cancer and Bioinforma;cs 1 NGS and Clinical Oncology NGS in hereditary cancer genome tes;ng BRCA1/2 (breast/ovary cancer) XPC (melanoma) ERCC1 (colorectal cancer) NGS for personalized cancer treatment
More informationWhole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute
Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes
More informationNEXT GENERATION SEQUENCING. R. Piazza (MD, PhD) Dept. of Medicine and Surgery, University of Milano-Bicocca
NEXT GENERATION SEQUENCING R. Piazza (MD, PhD) Dept. of Medicine and Surgery, University of Milano-Bicocca SANGER SEQUENCING 5 3 3 5 + Capillary Electrophoresis DNA NEXT GENERATION SEQUENCING SOLEXA-ILLUMINA
More informationEarly life metal exposure and epigene4cs: a transdisciplinary approach
Early life metal exposure and epigene4cs: a transdisciplinary approach Alison P. Sanders, PhD Postdoctoral Fellow Department of Preven4ve Medicine Icahn School of Medicine at Mount Sinai Trans- disciplinary
More informationGlioblastoma mul,forme
Glioblastoma mul,forme Glioblastoma mul,forme (GBM), or Glioblastoma, or Grade IV Astrocytoma is the most common and most aggressive malignant primary brain tumor. GBM is usually involving glial cells,
More informationModule 3: Pathway and Drug Development
Module 3: Pathway and Drug Development Table of Contents 1.1 Getting Started... 6 1.2 Identifying a Dasatinib sensitive cancer signature... 7 1.2.1 Identifying and validating a Dasatinib Signature... 7
More informationWhat s in your genes? Whole genome sequencing and its impact on personalized medicine
What s in your genes? Whole genome sequencing and its impact on personalized medicine Adrianna San Roman Clare Malone Leah Liu Photo by Micah Baldwin Personalized Medicine Tailoring of medical care based
More information